Pulmatrix, Inc. entered a merger agreement with Eos SENOLYTIX, Inc. on March 26, 2026, where Eos will become a wholly owned subsidiary. Post-merger, Eos stockholders will own approximately 94% of the combined company, while Pulmatrix stockholders will hold about 6%.